We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
Cap. Flow
+$404M
Cap. Flow %
6.55%
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313

Top Buys

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$197M
2
AGN
Allergan plc
AGN
+$135M
3
BHC icon
Bausch Health
BHC
+$129M
4
CVS icon
CVS Health
CVS
+$107M
5
MCK icon
McKesson
MCK
+$94.3M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$286M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$225M
3
GILD icon
Gilead Sciences
GILD
+$86.1M
4
PRGO icon
Perrigo
PRGO
+$79.4M
5
CAH icon
Cardinal Health
CAH
+$74.8M

Sector Composition

Rank Sector Weight
1 Healthcare 53.16%
2 Consumer Discretionary 5.06%
3 Energy 4.01%
4 Utilities 3.23%
5 Financials 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QLTI
51
DELISTED
QLT Inc
QLTI
$24.7M 0.4%
4,435,000
+955,000
+27% +$5.92M
EBAY icon
52
eBay
EBAY
$50.6B
$24.4M 0.4%
1,051,546
+757,466
+258% +$17.6M
FLNA
53
Filana Therapeutics
FLNA
$48.8M
$23.9M 0.39%
621,429
– –
CMCSK
54
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$23.8M 0.39%
488,590
+329,683
+207% +$16.1M
CTRX
55
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$23.8M 0.39%
532,120
+300,634
+130% +$14.5M
MOH icon
56
Molina Healthcare
MOH
$10.2B
$23.5M 0.38%
+625,500
New +$23M
OCR
57
DELISTED
OMNICARE INC
OCR
$23.4M 0.38%
392,522
+303,005
+338% +$18.4M
RARE icon
58
Ultragenyx Pharmaceutical
RARE
$2.45B
$22.3M 0.36%
+455,109
New +$23.4M
MDT icon
59
Medtronic
MDT
$109B
$21.7M 0.35%
352,400
+181,192
+106% +$10.6M
TWC
60
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$21.6M 0.35%
157,781
+142,268
+917% +$19.5M
SRE icon
61
Sempra
SRE
$57.9B
$21.5M 0.35%
444,594
-209,678
-32% -$9.75M
MRK icon
62
Merck
MRK
$322B
$21.3M 0.35%
394,063
-203,900
-34% -$10.6M
TSLA icon
63
PUT
Tesla
TSLA
$1.23T
$20.8M 0.34%
1,500,000
+1,485,000
+9,900% +$19.9M
EIX icon
64
Edison International
EIX
$28.2B
$20.4M 0.33%
360,738
+348,938
+2,957% +$17.4M
THI
65
DELISTED
TIM HORTONS INC COM, CANADA
THI
$20.3M 0.33%
+343,144
New +$18.5M
ITMN
66
DELISTED
INTERMUNE INC
ITMN
$20.2M 0.33%
602,456
-865,496
-59% -$19.3M
ARWR icon
67
Arrowhead Research
ARWR
$11.9B
$20M 0.32%
1,217,183
+681,151
+127% +$12M
CNQ icon
68
Canadian Natural Resources
CNQ
$99.4B
$18.9M 0.31%
1,021,309
+640,361
+168% +$10.8M
LITS
69
Lite Strategy Inc
LITS
$32.8M
$18.5M 0.3%
83,031
+21,366
+35% +$3.85M
GOOG icon
70
Alphabet (Google) Class C
GOOG
$4.36T
$18.4M 0.3%
664,401
+217,332
+49% +$6.33M
DGX icon
71
Quest Diagnostics
DGX
$25.7B
$18.4M 0.3%
317,012
+260,304
+459% +$14M
LYB icon
72
LyondellBasell Industries
LYB
$20B
$17.8M 0.29%
200,332
+68,162
+52% +$5.73M
ULTA icon
73
Ulta Beauty
ULTA
$22B
$17.8M 0.29%
182,545
+133,868
+275% +$12.1M
ILMN icon
74
Illumina
ILMN
$31B
$17.4M 0.28%
120,105
-18,107
-13% -$2.66M
A icon
75
CALL
Agilent Technologies
A
$39.1B
$17.2M 0.28%
431,143
+426,949
+10,180% +$17.6M
1 2
3
4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.

  • Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
  • Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
  • Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
  • Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
  • Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
  • Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
  • Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.

Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.